Trent Kitsch, CEO of DOJA (CSE:DOJA) Cannabis Company, will answer questions from cannabis investors about DOJA’s business, building lasting brands, the future of cannabis and many other topics on Reddit at:
In order to participate, you must create a Reddit account (it takes only a minute!).
This Reddit Ask Me Anything (AMA) is a way for DOJA to interact with investors in real time. We look forward to your questions.
About Trent Kitsch:
Trent founded SAXX Underwear Co. in 2007 and successfully built SAXX into a globally recognizable brand and the fastest growing underwear brand in North America before exiting the business in 2015. In 2013 Trent and his wife Ria founded Kitsch Wines, an award-winning winery in the Okanagan Valley. Trent is an MBA graduate of the Richard Ivey School of Business with a major in Entrepreneurship.
Reddit is an American social news aggregation, web content rating, and discussion website. Reddit’s registered community members can submit content such as text posts or direct links. Registered users can then vote submissions up or down that determines their position on the page. Submissions with the most up-votes appear on the front page or the top of a category.
Content entries are organized by areas of interest called “subreddits”. Subreddit topics include news, science, gaming, movies, music, books, fitness, food, image-sharing, and many others. The site prohibits harassment, and moderation requires substantial resources.
As of 2017, Reddit had 542 million monthly visitors (234 million unique users), ranking #4 most visited website in U.S. and #9 in the world. Across 2015, Reddit saw 82.54 billion pageviews, 73.15 million submissions, 725.85 million
For further information, please contact Jeff Barber by email at email@example.com.
The DOJA team also encourages readers to visit the website at www.doja.life to learn more about DOJA and to sign up for DOJA news updates.
– All Stockholder Proposals Were Approved –
– Transaction Expected to Close Early November –
Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW) (“Greenrose” or the “Company”), a special purpose acquisition company targeting companies in the cannabis industry, announced today that its shareholders voted to approve the proposed business combination (the “Business Combination”) with Connecticut-based Theraplant, LLC and the acquisition of certain assets of Arizona-based True Harvest, LLC.
Upon closing the Business Combination, which is expected to be in early November, the combined company will be named The Greenrose Holding Company and will continue to be listed on the OTC under the symbols “GNRSU,” “GNRS,” and “GNRSW.” Greenrose also intends to list on the NEO exchange as soon as practicable after the close of the Business Combination.
“We are grateful for the support of our shareholders and would like to thank them for sharing in our vision of developing and expanding our cannabis platform,” said Mickey Harley, CEO and Director of Greenrose. “Our team is ready to enter our next exciting growth phase, and we look forward to using the proceeds of this transaction to expand in our existing markets and target strategic assets in key states that present opportunities for further consolidation.”
Imperial Capital, LLC is acting as capital markets advisor to Greenrose. Gateway Group is serving as communications advisor to Greenrose. Mackenzie Partners and Broadridge Financial Solutions are acting as proxy advisors to Greenrose in connection with its proxy solicitation efforts.
Greenrose Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Greenrose has entered into definitive agreements to acquire four cannabis companies, known collectively as “The Platform.” The companies are Shango Holdings Inc. (Shango), Futureworks LLC (d/b/a The Health Center ), Theraplant , LLC and True Harvest , LLC. The new Greenrose Platform will be a multistate operator that will look to further vertically and horizontally integrate in the markets that it is in and to enter new high growth and limited license markets.
No Offer or Solicitation
This press release relates to the proposed Business Combination. This document does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Greenrose’s or its target companies’ control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: any inability to obtain Greenrose stockholder approval of the business combinations, any inability to complete the transaction contemplated by each of the respective merger or acquisition agreements because of failure of closing conditions or other reasons; any inability to recognize the anticipated benefits of the proposed business combinations, which may be affected by, among other things, the amount of cash available following any redemptions by Greenrose stockholders; liquidity of Greenrose’s stock; costs related to the proposed business combinations; Greenrose’s ability to manage growth; Greenrose’s ability to identify and integrate other future acquisitions; rising costs adversely affecting Greenrose’s profitability; competition in the legal cannabis industry; adverse changes to the legal environment for the cannabis industry; and general economic and market conditions impacting demand for Greenrose’s products and services. See the risk factors disclosed in the Definitive Proxy Statement for the business combinations for additional risks associated with the business combinations. None of Greenrose, Shango Holdings Inc., Futureworks LLC (d/b/a The Health Center), Theraplant, LLC, or True Harvest, LLC undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers should not unduly rely on any projections or other forward-looking statements or data contained herein.
Additional Information About the Proposed Business Combination and Where to Find It
For additional information about the proposed business combinations, see Greenrose’s Definitive Proxy Statement on Schedule 14A filed with the SEC on October 5, 2021 available at www.sec.gov.
Investor Relations Contact:
Gateway Investor Relations
Cody Slach or Jackie Keshner
Executive Vice President, Business Development
News Provided by GlobeNewswire via QuoteMedia
Vancouver, BC TheNewswire – October 27th, 2021 Quizam Media Corporation (“the Company”) (CSE:QQ) (CNSX:QQ.CN) is pleased to announce that the 2,000,000 Unit PP @ $0.20 is now closed .
The Unit Private Placement consists of 2,000,000 units of the Company at a price of $0.20 per unit. Each unit will consist of one common share and a ½ share purchase warrant exercisable at $0.40 for 18 months.
Subscription details are as follows: 11 Placees;
Insider Blueskyview Software Corp. (Russ Rossi) – 325,000 units;
Shares and warrants issued as a result of this Private Placement will be subject to a four month hold period expiring March 1st, 2022.
Quizam Media Corporation owns Quizam Entertainment, On-Track Corp. Training, OnTrackTV and Quantum 1 Cannabis. Through its wholly owned subsidiaries it is a producer, aggregator, marketer and broadcaster of movie entertainment and Online Virtual Learning. In addition, Quizam owns and operates a chain of BC Cannabis Dispensaries under the name Quantum1 ( www.quantum1cannabis.com )
CSE Trading Symbol: QQ
Telephone: (604) 683-0020
Email: firstname.lastname@example.org www.quizammedia.com
Facsimile: (604) 683-0045
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and nature of potential acquisitions, joint ventures, partnerships, business dealings and financings, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. Readers are cautioned not to place undue reliance on the forward-looking statements made in this Press Release.
Copyright (c) 2021 TheNewswire – All rights reserved.
News Provided by TheNewsWire via QuoteMedia
Quantum 1 Cannabis
Vancouver, BC TheNewswire – October 27 th 2021 Quizam Media Corporation (“the Company”) (C SE :QQ) (CNSX:QQ.CN) is pleased to announce that it has negotiated a non-brokered private placement of 2,000,000 units of the Company at a price of $0.20 per unit. Each unit will consist of one common share and a 12 share purchase warrant exercisable at $0.40 for 18 months. Insider CEO Russ Rossi will be subscribing to 325,000 units.
Quizam Media Corporation owns Quizam Entertainment, On-Track Corp. Training, OnTrackTV and Quantum 1 Cannabis. Through its wholly owned subsidiaries it is a producer, aggregator, marketer and broadcaster of movie entertainment and Online Virtual Learning. In addition, Quizam owns and operates a chain of BC Cannabis Dispensaries under the name Quantum1 (www.quantum1cannabis.com)
CSE Trading Symbol: QQ
Telephone: (604) 683-0020
Facsimile: (604) 683-0045
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This
news release may contain forward-looking statements including but not limited to comments regarding the timing and nature of
potential acquisitions, joint ventures, partnerships, business dealings and financings, etc. Forward-looking statements address future
events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. Readers are cautioned not to place undue reliance on the forward-looking statements made in this Press Release.
Copyright (c) 2021 TheNewswire – All rights reserved.
News Provided by TheNewsWire via QuoteMedia
Quantum 1 Cannabis
Medical cannabis company continues rapid expansion with opening of 104 th Florida dispensary
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), the largest cannabis multi-state operator (MSO) in the United States today announced the opening of a dispensary in Bartow, Florida . The Bartow location is Trulieve’s 104 th in the state. This dispensary joins the Company’s 103 additional medical marijuana dispensaries across Florida including those in nearby Winter Haven and Lakeland .
Trulieve invites the Bartow community to join the grand opening festivities, which include partner swag giveaways, custom t-shirt screen printing with St. Petersburg -based Craft Tee, and all-day deals. All registered patients will be eligible for a 25% in-store discount at the new Bartow dispensary on opening day, and all first-time Trulieve customers are eligible for a 50% new customer discount, both at Bartow and dispensaries across the state.
ANNOUNCING : Trulieve Bartow Grand Opening
WHERE : 1030 N Broadway Avenue, Suite 1D, Bartow, FL
WHEN : Thursday, October 28, 2021 , at 9:00am
As the state’s leading medical cannabis provider, Trulieve’s employees are experts in cannabis products and the process of becoming a medical cannabis patient. From those interested in applying for a card to patients already familiar with Trulieve’s wide array of products, Trulieve’s team looks forward to welcoming Bartow -area patients to the new dispensary and serving patients at every end of the cannabis experience spectrum.
In stores and online, patients will find Florida’s largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable flower, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers statewide home delivery, convenient online ordering and in-store pickup.
For more information, or to learn how to become a registered patient, please visit Trulieve.com .
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.
To learn more about Trulieve, visit trulieve.com .
SOURCE Trulieve Cannabis Corp.
News Provided by Canada Newswire via QuoteMedia
- Steven Lehrer’s 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D.
- His appointment continues to demonstrate the Company’s resolve to leverage its biotech technology platform in life science-based businesses.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announces that effective immediately, Steven Lehrer will be serving on its board of advisors. Complementing an already competent list of advisors that includes a significant array of expertise, Steven brings 40 years of experience in life science-based businesses to the Company.
Cannot view this image? Visit:
“I am excited to join the board of advisors of BioHarvest,” said Steven Lehrer. “I strongly believe in the potential of the proprietary BioFarming technology to make a significant impact on multiple verticals of the life science-based businesses. I look forward to working with my fellow advisors as well as with the Company’s Board and management to realize this potential.”
Ilan Sobel, CEO of BioHarvest, said: “Steven’s extensive experience in pharmaceutical, biopharmaceutical and biosimilar R&D, regulatory, operations and commercialization will be a great addition to the board of advisors. At this critical phase of the Company’s growth, Steven’s experience and involvement will play an important role in the Company’s quest to become a Biotech leader.“
Steven currently sits on the Board of Directors of two life science companies, one not for profit, and is a member of the University of Maryland’s Bioengineering Department Advisory Board. He provides strategy and implementation advice to several organizations on various topics from commercial efforts through operations, business development, product development, portfolio planning to the establishment of international operations. Previously Steve was Head of Biologicals at Cipla Ltd., CEO of Cipla BioTec, President of Glycominds Ltd, EVP of Adamas Pharmaceuticals Inc., CEO of GeneOs Ltd, CEO at DNA Sciences, and was a division President of Monsanto. Steven also worked with McKinsey & Co., and Proctor & Gamble Corporation.
Steven has led the development and commercialization of several biopharmaceuticals, biosimilar drugs and novel drug formulations, several genetic dagnostic tests and developed outcomes databases for bioinformatics and healthcare econometric modeling. Steven has built and run businesses in the USA, EU, Brazil, India, Japan, and SEA.
Steven has a Master’s Degree from The Graduate School of Business at Harvard University, a Bachelor of Sciences in Chemical Engineering, and a Bachelor of Art in Economics from the University of Maryland, College Park.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets. Visit: www.bioharvest.com.
BioHarvest Sciences Inc.
Ilan Sobel, Chief Executive Officer
For further information, please contact:
Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186
Information set forth in this news release might include forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that we will achieve our objective of making our products available in multiple markets and exposing our technology to different verticals. There is no assurance that the Company will be successful in expanding its technology to broader medical applications or conduct clinical trials to validate the efficacy of the Company’s products for new forms of medical treatments. Clinical trials are subject to risks of significant cost overruns and lengthy delays with no assurance they will confirm desired results. Even where desired results are obtained government approvals for treatments take considerable time and cannot be guaranteed. There is no assurance the BioFarming technology will make a significant impact on multiple verticals of life -science based businesses. There is no assurance that we will achieve our objective of being a leading supplier of Cannabis. Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. Projected sales of Cannabis will require the company to obtain production and / or export licensing which cannot be assured.
All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/100988
News Provided by Newsfile via QuoteMedia